On February 26, 2009, The Quigley Corporation (the "Company") issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2008. The full text of the press release is attached hereto as Exhibit 99.1.

The information furnished pursuant to Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 hereto, shall not be considered "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such section, nor shall it be incorporated by reference into future filings by the Company under the Securities Act of 1933, as amended or under the Securities Exchange Act of 1934, as amended, unless the Company expressly sets forth in such future filing that such information is to be considered "filed" or incorporated by reference therein.

On February 26, 2009, the Company issued a press release providing a summary on the status of its pharmaceutical pipeline. The full text of the press release is attached hereto as Exhibits 99.1.

(d) Exhibits.

          Exhibit No. Description

          99.1        Press Release dated February 26, 2009 reporting fourth quarter
                      and fiscal year ended December 31, 2008 preliminary unaudited
                      earnings and providing a summary on the status of the Company's
                      pharmaceutical pipeline.